Health News Archive - July 17, 2012
Ongoing E. coli outbreaks continue to infiltrate the food supply, despite numerous efforts to thwart the bacteria. However, researchers report that they are now gaining the upper hand.
Based on a number of studies, they concluded that naps could be linked to dementia and that the sleeping patterns of the elderly could help diagnose dementia.
A new study marks the beginning of important research that could potentially help develop and assess treatments for multiple sclerosis (MS).
Some think bariatric surgery can undo a lifetime's worth of eating habits, but new research presented at the Bariatric Surgery Conference in Fort Lauderdale, Florida, may make these people think again!
A drug used to treat sepsis that was once pulled for poisoning the blood, may be effective after all. The drug, known as drotrecogin alfa (activated) was approved for use in the United States in 2001, and in Europe in 2002, on the basis of the randomized, double-blind, placebo-controlled PROWESS study.
Researchers recently found that children who receive dental fillings made of bisphenol-A (BPA), a plastics chemical, could have behavioral changes that are small but be significant over a long period of time.
The FDA recently approved Truvada, which decreases the risk of HIV invention in uninfected individuals who have a high risk of contracting HIV Infection or who are engaged in sexual activities with a partner who is HIV-infected.
British pharmaceutical giant GlaxoSmithKline (GSK) has acquired US-based Human Genome Sciences (HGS) after tough negotiations saw it raise offers from an initial $2.6 billion in April, putting the final value of the deal at $3.6 billion or $14.25 per share.
Two new studies presented today at the Society for Nutrition Education and Behavior's (SNEB) annual conference may make it easier for moms to get their kids to eat – and enjoy – vegetables.
A team of scientists at The New York Stem Cell Foundation (NYSCF) Laboratory led by Scott Noggle, PhD, NYSCF–Charles Evans Senior Research Fellow for Alzheimer's Disease, has developed the first cell-based model of Alzheimer's disease (AD) by reprogramming skin cells of Alzheimer's patients to become brain cells that are affected in Alzheimer's.
- A terrible or repulsive person.